
Tetra Med Sciences sets up R&D centre
The Hindu
US firm Tetra Global’s subsidiary Tetra Med Sciences has set up a research and development centre in Hyderabad. Announcing launch of operations at the facility, Tetra Med Sciences in a release on Frid
US firm Tetra Global’s subsidiary Tetra Med Sciences has set up a research and development centre in Hyderabad. Announcing launch of operations at the facility, Tetra Med Sciences in a release on Friday said it is engaged in new molecule development and building a portfolio of molecules. The initial focus will be on developing molecules with their intermediates for APIs and going off-patent now and in coming 5-10 years and post getting the drug license work on finished API doses too, the company said. It aims to work on API and other domains and plans to have a production facility soon. For now, it has signed a 3rd party facility for immediate needs. The company is currently working on molecules for pharma and plans to roll out cost competent and non-infringing intermediates. The team has expertise in the fields of drug discovery, medicinal chemistry besides aroma chemicals, it said in the release.More Related News

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












